Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2012
10/04/2012WO2012078667A3 Compositions and methods relating to proliferative diseases
10/04/2012WO2012075440A4 Compositions and methods for delivering clonidine to a target tissue site
10/04/2012WO2012066537A3 Compositions for transdermal delivery of active agents
10/04/2012WO2012056402A3 Formulations and methods for attenuating respiratory depression induced by opioid overdose
10/04/2012WO2012053011A3 Ophthalmic compositions comprising brinzolamide
10/04/2012WO2012036585A8 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
10/04/2012WO2012006169A3 Compositions and methods for enhancement of nucleic acid delivery
10/04/2012WO2011090694A8 Orally administrable film dosage forms containing ondansetron
10/04/2012US20120255043 Microrna as a cancer progression predictor and its use for treating cancer
10/04/2012US20120253298 Layered tissue thickness compensator
10/04/2012US20120253191 Porphyrin nanovesicles
10/04/2012US20120252905 Drug delivery from rapid gelling polymer composition
10/04/2012US20120252861 Medical Compositions for Intravesical Treatment of Bladder Cancer
10/04/2012US20120252848 Liquid dosage forms of non-enterically coated acid-labile drugs
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/04/2012US20120252832 Abuse-resistant controlled-release opioid dosage form
10/04/2012US20120252794 Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
10/04/2012US20120252771 Implants and methods for treating inflammation-mediated conditions of the eye
10/04/2012US20120251637 Abuse-proofed dosage form
10/04/2012US20120251623 Method of administering an active ingredient using a chewable oral dosage from comprising texture masked particles
10/04/2012US20120251622 Cellulose gum and polyol troche
10/04/2012US20120251621 Nutritionally Enhanced Fraction From Rice Bran And Method of Lowering Insulin Resistance Using Same
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251619 MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/04/2012US20120251618 Delivery and formulation of engineered nucleic acids
10/04/2012US20120251617 Bi-functional shrna targeting stathmin 1 and uses thereof
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251615 Agent for intra-articular injection
10/04/2012US20120251614 Processed feeds, foods and biofuels and methods of making and using them
10/04/2012US20120251613 Method for treating vitiligo with a prostaglandin analogue
10/04/2012US20120251612 Wound Healing Device, Method for Making the Same and Method for Treating a Wound
10/04/2012US20120251611 Super-hydrophilic structures
10/04/2012US20120251610 Nicotine-containing patch preparation
10/04/2012US20120251607 Antimicrobial compositions, methods of preparation thereof, and uses thereof
10/04/2012US20120251597 End products incorporating short-cut microfibers
10/04/2012US20120251596 Nanoemulsion, method for its preparation and use
10/04/2012US20120251595 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing
10/04/2012US20120251594 Delivery of Submicrometer and Nanometer Aerosols to the Lungs Using Hygroscopic Excipients or Dual Stream Nasal Delivery
10/04/2012US20120251593 Silk fibroin-decorin scaffolds
10/04/2012US20120251591 Polymer carrier
10/04/2012US20120251590 Controlled release formulations of opioid and nonopioid analgesics
10/04/2012US20120251589 Devices and methods for weight control and weight loss
10/04/2012US20120251588 Coating Composition, Solid Preparation Coated Therewith, and Method for Preparing Solid Preparation
10/04/2012US20120251587 Diabetes treatment
10/04/2012US20120251586 Ligand-specific inhibition of attachment of immune cells to implantable biomaterials
10/04/2012US20120251585 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
10/04/2012US20120251584 Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
10/04/2012US20120251583 Methods of making nucleic acid nanostructures
10/04/2012US20120251464 Chalcones as enhancer of antimicrobial agents
10/04/2012US20120251463 Nicotinamide Riboside Kinase Compositions and Methods for Using the Same
10/04/2012US20120251462 Agent For Smoker Dehabituation
10/04/2012US20120251461 [((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy
10/04/2012US20120251460 Use of vanillin derivatives as a preservative, preservation method, compounds, and composition
10/04/2012US20120251450 Nanoparticles that preferentially associate with and kill diseased cells for diagnostic and therapeutic applications
10/04/2012US20120247993 Probiotic Compositions, Methods and Apparatus for Their Administration
10/04/2012US20120247982 Stabilized pharmaceutical product
10/04/2012DE102011015567A1 Dosage forms, useful e.g. for the acute treatment of stress-induced pathologies in the central nervous system and cardiovascular system, comprise beta blockers, which are in the form of liquid aerosols
10/04/2012DE102011015370A1 Preparing a matrix comprises preparing a mixture containing an active agent and a biopolymer e.g. alginate, gum arabic, locust bean gum, karaya gum, tara gum or tragacanth and extruding the obtained mixture
10/04/2012CA2837122A1 Methods and compositions for enhancing the uptake of therapeutic agents by target cells
10/04/2012CA2832066A1 Short -acting dihydropyridines (clevidipine) for use in reducing stroke damage
10/04/2012CA2831715A1 Pouch containing nicotine in free salt form
10/04/2012CA2831613A1 Delivery and formulation of engineered nucleic acids
10/04/2012CA2831600A1 Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
10/04/2012CA2831597A1 Topical skin care formulations comprising plant extracts
10/04/2012CA2831566A1 Menthol liquids composition
10/04/2012CA2831548A1 Solid preparation
10/04/2012CA2831506A1 Compositions for the treatment of neurologic disorders
10/04/2012CA2831471A1 Biodegradable compositions suitable for controlled release
10/04/2012CA2831469A1 Biodegradable compositions suitable for controlled release
10/04/2012CA2831427A1 Prodrugs of d-isoglutamyl-[d/l]-tryptophan
10/04/2012CA2831308A1 Intranasal benzodiazepine pharmaceutical compositions
10/04/2012CA2831218A1 Controlled release pharmaceutical dosage forms
10/04/2012CA2831184A1 Method for encapsulated therapeutic products and uses thereof
10/04/2012CA2830962A1 Otamixaban formulations with improved stability
10/04/2012CA2830948A1 Osmotic mediated release synthetic nanocarriers
10/04/2012CA2830806A1 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
10/04/2012CA2830664A1 Pegylated human hdl particle and process for production thereof
10/04/2012CA2830464A1 Composition containing a cellulose, a vegetable oil and a volatile solvent, and use thereof as a dressing
10/04/2012CA2830459A1 Film-forming composition containing a sun filter, and use thereof for the treatment of scars
10/04/2012CA2829791A1 Sustained-release injectable formulation
10/04/2012CA2829095A1 Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
10/04/2012CA2828700A1 Pharmaceutical composition containing block copolymer comprising boronic acid compound
10/04/2012CA2822177A1 Nanoparticles loaded with chemotherapeutic antitumoral drug
10/03/2012EP2505195A1 Topical pharmaceutical compositions of ketoprofen and methylsulfonylmethane
10/03/2012EP2505194A2 Nicotine-containing patch preparation
10/03/2012EP2505193A1 Anti - retroviral combination
10/03/2012EP2505192A1 Use of carriers as preservatives and pharmaceutical composition containing same
10/03/2012EP2505191A1 Lyophilized Carbapenem antibiotic composition
10/03/2012EP2505190A1 Polymorphic forms of ertapenem monosodium salt and process for it's preparation
10/03/2012EP2505189A1 Stabilizing alkylglycoside compositions and method thereof
10/03/2012EP2505188A1 Suppository for rectal, vaginal or urethral administration
10/03/2012EP2504428A2 Methods and compositions for treating oxalate-related conditions
10/03/2012EP2504353A2 Lipopeptide compositions and related methods
10/03/2012EP2504035A2 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
10/03/2012EP2504034A1 Topical ibuprofen formulations
10/03/2012EP2504033A1 Film-like pharmaceutical dosage forms
10/03/2012EP2504025A2 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
10/03/2012EP2504020A1 Formulations of daptomycin
10/03/2012EP2504019A2 Mucosal delivery composition comprising a peptide complexed with a crown compound and/or a counter ion
10/03/2012EP2504018A1 Antidiabetic composition comprising a plant extract of englerina lecardii
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 2991